Study outcomes | Ticargrelor (N = 56) | Clopidogrel (N = 57) | p value |
---|---|---|---|
Baseline measures | Â | Â | Â |
 Physical component summary | 51.2 ± 6.7 | 50.8 ± 7.2 | 0.78 |
  Physical functioning | 84.4 ± 17.2 | 83.3 ± 16.6 | 0.71 |
  Role physical | 87.3 ± 19.6 | 86.2 ± 19.5 | 0.73 |
  Bodily pain | 74.5 ± 24.6 | 73.2 ± 23.2 | 0.61 |
  General health | 57.8 ± 17.5 | 58.8 ± 17.5 | 0.53 |
 Mental component summary | 50.7 ± 6.7 | 50.3 ± 7.5 | 0.80 |
  Vitality | 59.4 ± 18.2 | 58.8 ± 18.8 | 0.85 |
  Social functioning | 91.4 ± 16.8 | 89.4 ± 18.6 | 0.69 |
  Role emotional | 88.6 ± 19.4 | 89.4 ± 18.6 | 0.81 |
  Mental health | 70.5 ± 14.9 | 70.7 ± 15.9 | 0.95 |
6-month measures | Â | Â | Â |
 Physical component summary | 55.6 ± 3.8 | 55.6 ± 3.9 | 0.97 |
  Physical functioning | 91.2 ± 11.4 | 90.6 ± 11.1 | 0.77 |
  Role physical | 95.4 ± 11.7 | 96.7 ± 8.4 | 0.48 |
  Bodily pain | 93.8 ± 13.2 | 94.4 ± 8.0 | 0.72 |
  General health | 62.6 ± 13.1 | 64.5 ± 13.4 | 0.16 |
 Mental component summary | 51.8 ± 3.9 | 51.4 ± 4.2 | 0.65 |
  Vitality | 63.2 ± 12.8 | 62.4 ± 13.1 | 0.75 |
  Social functioning | 99.0 ± 4.7 | 97.5 ± 12.7 | 0.18 |
  Role emotional | 97.2 ± 7.7 | 96.6 ± 9.9 | 0.76 |
  Mental health | 72.1 ± 8.9 | 72.1 ± 10.8 | 0.99 |